ОНКО НОВИНИ🧬Нови данни за Signatera™ подчертават потенциала на MRD-проследяването при рак на пикочния мехур. NM Genomix е доверен партньор за прецизния онкогенетичен тест Signatera™ и генетично консултиране в България.🔗 Цялата новина: www.natera.com/company/news... Обадете ни се! ☎️ 0885 443 975

Show Post

You launch your first product. What's the better milestone? - 1,000 free users - 10 paying customers #Startups #SaaS #BuildInPublic

Show Post

There's beauty and there's tacky. The white house looks tacky.

Show Post

As of now, I've had two lit journalism outlets either pass on doing anything with this or show major hesitation, despite significant public developments and the absurdly extensive record of publication here.

Show Post

Jensen's question for Congress: not just how many launched effects the services are buying, but which headquarters will command swarms and how quickly they can generate pulses. Read his recommendations: https://www.csis.org/analysis/art-swarming

Show Post